UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
FORM 8-K
CURRENT REPORT PURSUANT
TO SECTION 13 OR 15(D) OF THE
SECURITIES EXCHANGE ACT OF 1934
|
Date of report (Date of earliest event reported) |
May 5, 2006 |
|
STEREOTAXIS, INC. |
|
(Exact Name of Registrant as Specified in Its Charter) |
|
Delaware |
|
(State or Other Jurisdiction of Incorporation) |
|
000-50884 |
94-3120386 |
|
(Commission File Number) |
(IRS Employer Identification No.) |
|
4320 Forest Park Avenue, Suite 100, St. Louis, Missouri |
63108 |
|
(Address of Principal Executive Offices) |
(Zip Code) |
|
(314) 678-6100 |
|
(Registrant’s Telephone Number, Including Area Code) |
|
|
|
(Former Name or Former Address, if Changed Since Last Report) |
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
|
|
o |
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
|
|
o |
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
|
|
o |
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
|
|
o |
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Item 1.01. Entry into a Material Definitive Agreement.
On May 5, 2006, Stereotaxis, Inc. (the “Company”) entered into an amendment (the “Amendment”) to the Extended Collaboration Agreement dated May 27, 2003 and the Collaboration Agreement dated June 8, 2001, in each case between the Company and Siemens Aktiengesellschaft, Medical Solutions (collectively, the “Collaboration Agreement”). The Amendment extends the Collaboration Agreement through May 1, 2009, and provides for automatic renewals for successive one-year periods until terminated by either party upon at least six months advance notice or as otherwise provided for in the Collaboration Agreement.
Item 7.01. Regulation FD Disclosure
On May 17, 2006, the Company issued a press release announcing its entry into the Amendment to the Collaboration Agreement as described in item 1.01.
Note: The information furnished in this Item 7.01, including Exhibit 99.1 attached hereto, is being furnished and shall not be deemed to be “filed” for the purposes of Section 18 of the Securities Exchange Act of 1934 (the “Exchange Act”) or otherwise subject to the liabilities of that section, or incorporated by reference in any filing under the Securities Act of 1933 or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing. This report, including Exhibit 99.1, will not be deemed a determination or an admission as to the materiality of any information in the report that is required to be disclosed solely by Regulation FD.
|
Item 9.01. Financial Statements and Exhibits. |
|
(d) |
Exhibits. |
|
99.1 |
Stereotaxis, Inc. Press Release dated May 17, 2006 |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|
|
STEREOTAXIS, INC. | |
|
|
|
|
|
Date: May 17, 2006 |
By: |
/s/ James M. Stolze |
|
|
Name: |
James M. Stolze |
|
|
Title: |
Vice President and Chief Financial Officer |
EXHIBIT INDEX
|
Exhibit No. |
Document |
|
99.1 |
Stereotaxis, Inc. Press Release dated February 23, 2006. |